Steven Bai

Aging Increases Pharmacodynamic Sensitivity to the Hypnotic Effects of Midazolam

James Jacobs, J. G. Reves, J. Marty et al. · Anesthesia & Analgesia · 1995 · 124 citations

Medicine, Pharmacokinetics, Pharmacology +17

Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: comparison of computer-assisted versus manual infusion systems

David R. Theil, Thomas E. Stanley, William D. White et al. · Journal of Cardiothoracic and Vascular Anesthesia · 1993 · 76 citations

Medicine, Anesthesiology, Surgery +14

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-<i>N</i>- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1<i>H</i>-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

James R. Pruitt, Donald Pinto, Robert A. Galemmo et al. · Journal of Medicinal Chemistry · 2003 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa

Donald Pinto, Michael J. Orwat, Mimi L. Quan et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-<i>a</i>]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF₁) Antagonists

Paul J. Gilligan, Todd Clarke, Liqi He et al. · Journal of Medicinal Chemistry · 2009 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11